Animal Vaccine Market to Grow with a CAGR of 8.18% through 2029
Increased prevalence of animal disease and increasing
pet adoption globally is expected to drive the Global Animal Vaccine Market
growth in the forecast period, 2025-2029.
According to
TechSci Research report, “Animal Vaccine Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2029F”, the
Global Animal Vaccine Market stood at USD 7.68 billion in 2023 and is
anticipated to grow with a CAGR of 8.18% in the forecast period, 2025-2029. Growing
concerns regarding food security and the rise in animal husbandry practices are
driving the demand for animal vaccines in the livestock industry. The
increasing demand for animal products has resulted in substantial growth in
global livestock production.
Factors such as
changing lifestyles, population growth, and evolving food preferences have
further fueled the demand for livestock products. These factors have
significantly contributed to the market's growth. Additionally, the continuous
introduction of technologically advanced vaccines and the occurrence of
livestock diseases have played a pivotal role in shaping the market dynamics.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Animal Vaccine Market”
The increasing
prevalence of zoonotic diseases, which are diseases that can be transmitted
from animals to humans, poses a significant threat to human lives. As a result,
there is a growing demand for animal vaccines to combat these diseases. Not
only do emerging and exotic animal diseases jeopardize the health of both
humans and animals, but they also have the potential to disrupt food security.
The rise in both human and animal populations, coupled with environmental
degradation and globalized trade and travel, creates a fertile ground for the
transmission of pathogens between species. This interplay between humans,
animals, and the environment creates complex challenges that must be addressed
to safeguard public health. In many parts of the world, the increasing demand
for animal protein has led to a significant expansion of commercial food animal
production. However, this intensification of animal production also increases
the risk of emerging zoonotic diseases, which can have detrimental effects on
public health. Looking ahead, it is inevitable that the world will continue to
face emerging disease outbreaks in the coming decades. Therefore, the role of
animal vaccines in controlling and preventing these diseases becomes crucial.
Animal vaccines not only protect animals from infectious agents but also help
in mitigating the risk of transmission to humans.
Additionally,
rising concerns about food security, coupled with increased animal husbandry
practices, are contributing to the growing demand for livestock vaccines. The
global increase in demand for animal products has led to a significant
expansion of livestock production.
Moreover,
changing food preferences driven by evolving lifestyles and population growth
further boost the demand for livestock products. These factors, along with the
continuous introduction of technologically advanced vaccines and occasional
outbreaks of livestock diseases, are shaping the dynamics of the livestock
vaccine market. Furthermore, the wider acceptance of ruminant vaccines,
particularly cattle vaccines, is driven by increased outbreaks of animal
diseases and the ever-growing livestock population worldwide. Animals provide
not only meat and protein but also other commercial products such as milk,
wool, and leather. To protect the health and well-being of animals and prevent
the transmission of infectious agents, vaccines such as rabies vaccines, equine
influenza virus vaccines, and foot and mouth disease vaccines are commonly
used. In conclusion, the increasing prevalence of zoonotic diseases and the
need for food security are driving the demand for animal vaccines. The
intricate relationship between humans, animals, and the environment
necessitates robust measures to control and prevent the spread of diseases. The
continuous advancements in vaccine technology and the understanding of emerging
diseases will play a vital role in ensuring the health and safety of both
animals and humans.
The Global Animal
Vaccine Market is segmented into product, animal type, route of administration,
distribution channel, regional distribution, and company.
Based on its animal
type, the livestock segment emerged as the dominant animal type in the global animal vaccine market. Livestock farming plays a pivotal
role in meeting the growing demand for meat, dairy, and other animal-derived
products worldwide. With an increasing global population and rising disposable
incomes, there is a heightened demand for high-quality animal protein, driving
the expansion of the livestock sector. Consequently, the need to safeguard
livestock health and productivity against infectious diseases becomes
paramount. Vaccination serves as a cornerstone in disease prevention and
control within livestock populations, enabling farmers to mitigate the economic
losses associated with disease outbreaks and maintain the overall health and
productivity of their herds. Additionally, advancements in veterinary medicine
and biotechnology have facilitated the development of a diverse range of
vaccines tailored to address the specific health challenges faced by different
livestock species, including cattle, poultry, swine, and sheep.
Based on region,
North America segment is expected to grow during the forecast period. North
America emerged as the dominant market and is projected to maintain its
position throughout the forecast period. This dominance can be attributed to
the high prevalence of livestock and zoonotic diseases, leading to substantial
animal mortality. Additionally, the considerable presence of well-established pharmaceutical
companies, committed to broad commercialization of their vaccines and expanding
their market reach, is expected to drive market growth. Moreover, the
increasing incidence of canine disorders, driving vaccination adoption, and the
growing pet population in the United States are key factors contributing to the
regional market's expansion. Meanwhile, Asia Pacific is anticipated to exhibit
the highest growth rate during the forecast period. The projected rise in
livestock population and government initiatives, particularly in developing
economies, are primary drivers for market growth in the region. With a large
cattle population, there is a high demand for vaccines. The market is further
propelled by significant R&D investments by major players and efforts to
commercialize veterinary vaccines and inoculations at affordable prices.
Major companies
operating in Global Animal Vaccine Market are:
- Zoetis Inc.
- Merck & Co., Inc.
- Boehringer Ingelheim International
GmbH
- Biogenesis Bago
SA
- Indian Immunologicals Ltd.
- Elanco Animal Health Incorporated
- Phibro Animal Health Corporation
- Neogen Corporation
- Intas Pharmaceuticals Ltd.
- Ouro Fino Saude
Animal
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“Rising concerns
about food security, coupled with the growing need for animal husbandry, have
significantly increased the demand for livestock vaccines. As the demand for
animal products continues to rise, livestock production has witnessed a global
surge. Moreover, shifting food preferences driven by evolving lifestyles and
population growth have further fueled the demand for high-quality livestock
products. To address the evolving market dynamics, there has been a continuous
introduction of technologically advanced vaccines. These innovative vaccines
not only provide effective disease prevention but also contribute to the
overall improvement of animal health and welfare. Additionally, outbreaks of
livestock diseases have served as a wake-up call, highlighting the importance
of proactive vaccination strategies and reinforcing the need for robust
veterinary healthcare systems. In this ever-changing landscape, stakeholders
across the livestock industry are increasingly recognizing the critical role
that vaccines play in ensuring the well-being of animals and the sustainability
of livestock production. By investing in research and development, leveraging
technological advancements, and fostering collaborations, the industry is
poised to meet the growing demand for livestock vaccines and address the
emerging challenges in a proactive and efficient manner.,” said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based management
consulting firm.
“Animal Vaccine Market - Global Industry Size,
Share, Trends, Opportunity, and Forecast, Segmented By Product (Attenuated Live
Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant
Vaccines), By Animal Type (Livestock, Companion, Others), By Route Of
Administration (Subcutaneous, Intramuscular, Intranasal), By Distribution
Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug
Stores, Others), By Region and Competition, 2019-2029F”, has evaluated
the future growth potential of Global Animal Vaccine Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Animal Vaccine Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com